| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/11/2000 | US6087336 Peptide derivatives useful in treating autoimmune diseases |
| 07/11/2000 | US6087330 Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor |
| 07/11/2000 | US6087325 Peptide-lipid conjugates |
| 07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
| 07/11/2000 | US6087120 Detection of immune response in blood; incubation of a bioactive molecules in vitro with anticoagulant, screen for formation of bound enzyme, detect cleavage of substrate |
| 07/11/2000 | CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 07/06/2000 | WO2000039153A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 07/06/2000 | WO2000039124A1 Thrombin inhibitors |
| 07/06/2000 | WO2000039119A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | WO2000039075A1 N-3, 3-DIMETHYLBUTYL-L-ASPARTIC ACID AND ESTERS THEREOF, THE PROCESS OF PREPARING THE SAME, AND THE PROCESS FOR PREPARING N-[N-(3, 3-DIMENTHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER THEREFROM |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356777A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2355744A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | CA2355281A1 Thrombin inhibitors |
| 07/05/2000 | EP1016405A2 Arylating medicaments |
| 07/05/2000 | EP1015627A1 Method for detecting a target compound using a nucleic acid ligand |
| 07/05/2000 | EP1015479A1 Combinatorial libraries of peptidomimetic macrocycles and processes therefor |
| 07/05/2000 | EP1015439A1 Prenyl transferase inhibitors |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
| 07/05/2000 | CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component |
| 07/05/2000 | CN1258672A Amino-compound |
| 07/04/2000 | US6084112 Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones |
| 07/04/2000 | US6084065 Oligopeptides with fungicidal activity |
| 07/04/2000 | US6083917 Farnesyltransferase inhibitor peptide having specified tetrapeptide sequence |
| 07/04/2000 | US6083908 Compounds with growth hormone releasing properties |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug |
| 06/29/2000 | WO2000037486A1 Synthesis and recovery of aspartame involving enzymatic deformylation step |
| 06/29/2000 | WO2000037444A1 Compounds useful in the treatment of inflammatory diseases |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000012506A3 Collections of compounds |
| 06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
| 06/29/2000 | CA2355630A1 Compounds useful in the treatment of inflammatory diseases |
| 06/28/2000 | EP1013663A1 Synthesis and recovery of aspartame involving enzymatic deformylation step |
| 06/28/2000 | EP1012172A1 Acylated peptide cytolytic peptide inhibitors |
| 06/28/2000 | EP1012170A1 Metal complexes of n-[n-3 (3, 3-dimethylbutyl) - l-&-aspartyl]-l-phenylalanine 1-methyl ester |
| 06/28/2000 | EP1012169A1 SWEETENER SALTS OF N- N-(3,3-DIMETHYLBUTYL) -L-$g(a)-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 06/28/2000 | EP1012168A1 ACID SALTS OF N- N-(3,3-DIMETHYLBUTYL)-L-$g(a)-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 06/28/2000 | EP1012167A1 BASIC SALTS OF N- N-(3,3-DIMETHYLBUTYL)-L-$g(a)-ASPARTYL]-L-PHE NYLALANINE 1-METHYL ESTER |
| 06/28/2000 | EP1012166A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 06/28/2000 | EP1012165A1 Process for the preparation of n-methyl-d-phenylalanyl-n- 1- 3- (aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide |
| 06/28/2000 | EP1012164A1 Serine protease inhibitors |
| 06/28/2000 | EP1011736A2 Polymers |
| 06/28/2000 | EP1011668A1 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives |
| 06/28/2000 | CN1053908C Substd. thiazolo [3,2-a] azepine deriv. |
| 06/27/2000 | US6080838 Peptidomimetic of helix-turn-helix or gamma-turn |
| 06/27/2000 | US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| 06/27/2000 | US6080756 Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
| 06/27/2000 | US6080738 Heterocyclic amide compounds and medicinal uses thereof |
| 06/27/2000 | US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity |
| 06/27/2000 | CA2180000C Amino-acid amide derivatives, method for producing the same, and agricultural or horticultural fungicides |
| 06/22/2000 | WO2000036136A1 Metallopeptide combinatorial libraries and applications |
| 06/22/2000 | WO2000035942A1 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 06/22/2000 | WO2000035941A2 Combinatorial process for preparing polyamines |
| 06/22/2000 | WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035488A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/22/2000 | CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2355880A1 Process for preparing polyamines |
| 06/22/2000 | CA2355818A1 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 06/22/2000 | CA2353072A1 Metallopeptide combinatorial libraries and applications |
| 06/22/2000 | CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2349333A1 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2346935A1 Vitronectin receptor antagonist pharmaceuticals |
| 06/21/2000 | EP1010705A1 Novel cyclic tetrapeptide derivatives and medicinal use thereof |
| 06/21/2000 | EP1009770A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 06/21/2000 | EP1009758A1 Meta-benzamidine derivatives as serine protease inhibitors |
| 06/21/2000 | EP1009420A1 Conjugates useful in the treatment of prostate cancer |
| 06/20/2000 | US6077962 N-3, 3-dimethylbutyl-L-aspartic acid and esters thereof, the process of preparing the same, and the process for preparing N-(N-(3,3-dimethylbutyl) -α L-aspartyl)-L- phenylalanine 1-methyl ester therefrom |
| 06/20/2000 | US6077856 Hemoregulatory compounds |
| 06/20/2000 | US6077855 Hemoregulatory compounds |
| 06/20/2000 | US6077699 Purified nucleotide sequence of orf1 gene of streptomyces pristinaespiralis or its complement; for recombinant production of known and novel antibiotics |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/15/2000 | WO2000034452A1 Glucoamylases with n-terminal extensions |
| 06/15/2000 | WO2000034314A1 Pharmaceutical compositions comprising quinapril magnesium |
| 06/15/2000 | WO2000034313A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | WO2000033888A2 Prodrug compounds and process for preparation thereof |
| 06/15/2000 | WO2000012547A3 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use |
| 06/15/2000 | CA2354766A1 Prodrug compounds and process for preparation thereof |
| 06/15/2000 | CA2352740A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | CA2352046A1 Glucoamylases with n-terminal extensions |